REFERENCES
- Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD; CONSORT PRO Group. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA. 2013;309(8):814–822.
- Case reports search results. Bethesda, MD: PubMed, US National Library of Medicine; 2013. Available at: http://www.ncbi.nlm.nih.gov/pubmed/?term=case+reports. Accessed June 10, 2013.
- Cases Database. Available at: http://www.casesdatabase.com/. Accessed June 17, 2013.
- Hauben M, Aronson JK. Gold standards in pharmaco-vigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore. Drug Saf. 2007;30(8):645–655.
- Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295.
- Hirst A, Altman DG. Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. PLoS ONE. 2012;7(4):e35621. doi:10.1371/journal.pone.0035621.
- Hopewell S, Clarke M, Moher D, Wagner E, Middleton P, Altman DG, Schulz K, and the CONSORT Group. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med. 2008;5(1):e20. doi:10.1371/journal. pmed.0050020.
- Hopewell S, Ravaud P, Baron G, Boutron I. Effect of editors implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis. BMJ. 2012;344:e4178. doi: 10.1136/mj.e4178.
- Horton JN. Nominal group technique: a method of decision-making by committee. Anaesthesia. 1980;35(8):11–14.
- Jenicek M. Clinical case reporting in evidence-based medicine (2nd ed.). New York: Oxford University Press, 2001.
- Journal of Medical Case Reports. Available at: http://www.jmedicalcasereports.com./ Accessed June 17, 2013.
- Kaszkin-Bettag M, Hildebrandt W. Case report on cancer therapies: the urgent need to improve the reporting quality. Global Adv Health Med. 2012;1(2):8–10. doi: 10.7453/ gahmj.2012.1.2.002.
- Kelly WN, Arellano FM, Barnes J, Bergman U, Edwards RI, Fernandez AM, Glodsmith DI, Huang KA, Jones JK, McLeary R, Moore N, Stather RH, Trenque T, Troutman WG, van Puijenbroek E, Williams F, Wise RP; International Society for Pharmacoepidemiology, International Society of Pharmacovigilance. Guidelines for submitting adverse event reports for publication. Drug Saf. 2007;30(5):367–373
- Kiene H, Hamre H, Kienle G. In support of clinical case reports: a system of causality assessment. Global Adv Health Med. 2013;2(2):76–87. doi: 10.7453/gahmj.2012.061.
- Kljakovic M. Single cases in general practice and general medical journals. Aust Fam Physician. 2002;31(7):669–673.
- Levy M. Propranolol for infantile hemangiomas. Global Adv Health Med. 2012;1(2):14–16. doi:10.7453/gahmj.2012.1.2.004
- Moher D, Liberati A, Tetzlaff J, Altman DG; the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med 2009 6(7):e1000097. doi:10.1371/journal.pmed.1000097.
- Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med. 2010;7(2):e1000217. doi:10.1371/journal.pmed.100217.
- Richason TP, Paulson SM, Lowenstein SR, Heard KJ. Case reports describing treatments in the emergency medicine literature: missing and misleading information. BMC Emerg Med. 2009;9:10.
- Riley D. Case reports in the era of clinical trials. Global Adv Health Med. 2013;2(2):10–11.
- Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726–732.
- Thomas B. Using nominal group technique to identify researchable problems. J Nurs Educ. 1983;22(8):335–337.
- Tully MP, Cantrill JA. Exploring the domains of appropriateness of drug therapy using the nominal group technique. Pharm World Sci. 2002;24(4):128–131.
- Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev. 2012;1(1):60. doi:10.1186/2046-4053-1-60.
- Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med. 2001;134(4):330–334.
- Vandenbroucke JP. Thalidomide: an unanticipated adverse effect. JLL bulletin: commentaries on the history of treatment evaluation. Available at: http://www.jameslindlibrary. org/illustrating/articles/thalidomide-an-unanticipated-adverse-effect Accessed January 10, 2013.
- von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806–808.
- Williams PL, Webb C. The Delphi technique: a methodological discussion. J Adv Nurs. 1994;19(1):180–186.